Assistant Professor of Ophthalmology and Visual Science
The Ocular Oncology Section is led by Dr. Renelle Lim. Ocular tumors can be benign or malignant. Malignant tumors of the eye are life-threatening conditions affecting patients without distinction of age, gender or race.
The goal of the Ocular Oncology Section at Yale is to improve the prognosis of these rare diseases in terms of life, conservation of the eye and sight.
We provide diagnosis and treatment of the following (among others):
- Benign tumors (like choroidal nevus, choroidal hemangiomas)
- Malignant melanoma (iris, ciliary body, choroid, conjunctiva, eyelid, orbit and metastatic melanoma to the eye)
- Retinoblastoma (most common intraocular malignancy in children)
- Ocular metastasis from systemic cancers
- Retinal tumors (retinal hemangioblastomas also known as retinal capillary hemangiomas, and other vascular tumors, astrocytic tumors, adenomas and adenocarcinomas of the retinal pigment epithelium, and others)
- Conjunctival tumors
Our Ophthalmic oncology program is the only University based center in the state of Connecticut. At the state of the art Smilow Cancer center, first year residents examine patients with ophthalmic oncologic conditions and assist with surgery.
Ocular Oncology Faculty
- Dr. Lim is Director of the Ocular Oncology Program. Dr. Lim completed her fellowships in Ocular Oncology and Oculoplastic and Orbital Surgery at Wills Eye Hospital. She completed medical school training and residency at Downstate Medical Center in New York. Dr. Lim has authored over 30 peer reviewed publications and presents her research for national and international audiences. She is an editor for the Academy of Ophthalmology ONE Network Ocular Oncology division. Dr. Lim works with an outstanding team of specialists at Smilow Cancer Center to provide comprehensive care for patients with oncologic eye disease. Her clinical interests include: uveal melanoma, eyelid and orbital tumors, eyelid reconstruction, and eyelid malposition. She is available for consultation for all disorders involving cancer in the eye and periocular region, as well as functional and cosmetic oculoplastic surgery.